Phase i clinical studies, single and multiple-dose safety and pharmacokinetics clinical study of resveratrol, WS #41
Ended Definitive Contract Awarded Last action
- Contract number
- 00261200209D261025025
- Awardee
-
University Of Michigan UEI NKHYP5XEBMG6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,781,888
Award facts
- Contract value 25% obligated
-
- $6,891,668.00 Current, with exercised options
- $7,128,612.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer
- Pricing
- Cost No Fee
- Place of performance
- Ann Arbor, MI 48109, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $236,944 | |
| Funding Only Action | $300,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $536,944 | |
| Original award | $708,000 |
Show all 13
About this award
The U.S. government awarded a $7,128,612.00 definitive contract to the University of Michigan for a Phase I clinical study on the safety and pharmacokinetics of resveratrol (WS #41). The contract, which does not have a set-aside designation, was awarded on September 15, 2002 with a target completion date of December 29, 2009. The contract is a cost-no-fee arrangement, meaning the University of Michigan will be reimbursed for allowable costs but will not receive an additional fee. The study is being conducted in Ann Arbor, Michigan.
Quick answers
Who was awarded contract 00261200209D261025025?
00261200209D261025025 was awarded to University Of Michigan by National Cancer Institute (National Institutes of Health) on September 15, 2002.
How much is contract 00261200209D261025025 worth?
The government has obligated $1,781,888 on 00261200209D261025025. Its current value, with exercised options, is $6,891,668. Its potential value, with all options, is $7,128,612.
Was contract 00261200209D261025025 competed?
The extent of competition for 00261200209D261025025 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award